Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in Type 1 diabetes mellitus

被引:34
作者
McKenna, K [1 ]
Smith, D [1 ]
Tormey, W [1 ]
Thompson, CJ [1 ]
机构
[1] Beaumont Hosp, Ctr Diabet, Dublin 9, Ireland
关键词
atrial natriuretic peptide; brain natriuretic peptide; diabetes mellitus;
D O I
10.1046/j.1464-5491.2000.00318.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To examine the effect of acute hyperglycaemia on atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) concentrations in Type 1 diabetes. Methods The study was two limb, randomized, and single-blind. Eight Type 1 diabetes subjects were clamped at euglycaemia by intravenous infusion of insulin. When euglycaemia was established, the insulin infusion rate was left unaltered for the remainder of the protocol, and an intravenous infusion of either 500 ml 0.9% saline or 500 ml 10% dextrose was administered over 1 h. Blood was collected for estimation of plasma glucose, ANP and BNP concentrations at 30 min intervals for 2 h from the start of the infusion period. One week later, each subject received the alternate infusion. Results are expressed as mean +/- standard deviation, and were analysed by ANOVA. Results Baseline plasma glucose (P = 0.8), ANP (P = 0.8) and BNP (P = 0.8) concentrations were similar on the study days. Plasma glucose rose with dextrose (6.1 + 0.5-15.1 + 2.8 mmol/l, P = 0.9). Plasma ANP concentrations were unaltered by saline infusion (76.5 +/- 14.7-77.7 +/- 15.2 pg/ml, P = 0.9), but increased with dextrose infusion (79 +/- 14-134 +/- 17.1 pg/ml, P < 0.0001), and were higher with dextrose than saline infusion (P < 0.0001). Plasma concentrations of BNP were not significantly altered by infusion of either dextrose (5.1 +/- 3.9-9.3 +/- 5.4 pg/ml, P = 0.63) or saline (4.3 +/- 3.5-6 +/- 5.2 pg/ml, P = 0.84). Conclusions Plasma concentrations of ANP, but not BNP, rise in response to acute hyperglycaemia in Type 1 diabetes.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 39 条
[1]   GLOMERULAR-FILTRATION RATE IN STREPTOZOCIN-INDUCED DIABETIC RATS - ROLE OF EXCHANGEABLE SODIUM, VASOACTIVE HORMONES, AND INSULIN THERAPY [J].
ALLEN, TJ ;
COOPER, ME ;
OBRIEN, RC ;
BACH, LA ;
JACKSON, B ;
JERUMS, G .
DIABETES, 1990, 39 (10) :1182-1190
[2]   OSMOREGULATION OF VASOPRESSIN SECRETION AND THIRST IN HEALTH AND DISEASE [J].
BAYLIS, PH ;
THOMPSON, CJ .
CLINICAL ENDOCRINOLOGY, 1988, 29 (05) :549-576
[3]   INCREASED PLASMA ATRIAL NATRIURETIC FACTOR AND REDUCED PLASMA-RENIN IN PATIENTS WITH POORLY CONTROLLED DIABETES-MELLITUS [J].
BELL, GM ;
BERNSTEIN, RK ;
LARAGH, JH ;
ATLAS, SA ;
JAMES, GD ;
PECKER, MS ;
SEALEY, JE .
CLINICAL SCIENCE, 1989, 77 (02) :177-182
[4]  
BUCKLEY MG, 1992, CLIN SCI, V82, P127
[5]   RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE DURING HYPERTONIC SALINE INFUSION - THE IMPORTANCE OF POSTURE [J].
BURRELL, LM ;
BAYLIS, PH .
CLINICAL ENDOCRINOLOGY, 1990, 32 (04) :491-496
[6]   GLUCOSE CONTROL AND THE RENAL AND RETINAL COMPLICATIONS OF INSULIN-DEPENDENT DIABETES [J].
CHASE, HP ;
JACKSON, WE ;
HOOPS, SL ;
COCKERHAM, RS ;
ARCHER, PG ;
OBRIEN, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (08) :1155-1160
[7]   EFFECT OF GLUCOSE, INSULIN, AND HYPERTONICITY ON ATRIAL-NATRIURETIC-PEPTIDE LEVELS IN MAN [J].
CLARK, BA ;
SCLATER, A ;
EPSTEIN, FH ;
ELAHI, D .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (02) :224-228
[8]   ATRIAL-NATRIURETIC-FACTOR IN HYPERTENSIVE AND NORMOTENSIVE DIABETIC-PATIENTS [J].
FERRI, C ;
PICCOLI, A ;
LAURENTI, O ;
BELLINI, C ;
DEMATTIA, G ;
SANTUCCI, A ;
BALSANO, F .
DIABETES CARE, 1994, 17 (03) :195-200
[9]   ROLE OF ATRIAL-NATRIURETIC-PEPTIDE IN THE PATHOGENESIS OF SODIUM RETENTION IN IDDM WITH AND WITHOUT GLOMERULAR HYPERFILTRATION [J].
FIORETTO, P ;
SAMBATARO, M ;
CIPOLLINA, MR ;
GIORATO, C ;
CARRARO, A ;
OPOCHER, G ;
SACERDOTI, D ;
BROCCO, E ;
MOROCUTTI, A ;
MANTERO, F ;
GATTA, A ;
NOSADINI, R .
DIABETES, 1992, 41 (08) :936-945
[10]  
FIRTH R, 1993, DIABETOLOGIA, V36, pA217